Archives20242023202220212020201920182017201620152014201320122011 November 03, 2011ImmuPharma’s Lupuzor™ given approval to start phase III and Fast Track designation by the FDA Read More October 21, 2011ImmuPharma regains Lupuzor rights from Cephalon due to Teva merger Read More
November 03, 2011ImmuPharma’s Lupuzor™ given approval to start phase III and Fast Track designation by the FDA Read More
